Pediatric Trials

Genomic Analysis of Pediatric Bone Tumors

To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Eligibility


Inclusion Criteria:All patients with bone x-rays suggestive of a malignant bone tumor

Exclusion Criteria:Patients with a known diagnosis of cancer.

Ages Eligible for Study

N/A - 18 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Alejandro Sweet-Cordero
650-725-5901
Recruiting